Can MHC Class II Molecules be Targeted Therapeutically?
Yes, MHC Class II molecules can be targeted for therapeutic purposes, particularly in the context of autoimmune diseases and transplant rejection. Strategies may include the use of [monoclonal antibodies]() to block antigen presentation or the development of vaccines that modulate MHC Class II-mediated immune responses.
